ATRA icon

Atara Biotherapeutics

139 hedge funds and large institutions have $316M invested in Atara Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 53 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

16% less capital invested

Capital invested by funds: $376M → $316M (-$59.9M)

46% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 24

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.13M
Puts
$26K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.72M
27
$1.51M
28
$1.48M
29
$1.44M
30
$1.29M
31
$1.23M
32
$1.17M
33
$1.05M
34
$1.02M
35
$942K
36
$909K
37
$706K
38
$683K
39
$655K
40
$635K
41
$627K
42
$627K
43
$601K
44
$596K
45
$595K
46
$580K
47
$541K
48
$485K
49
$469K
50
$456K